🎙️ Podcast Version Non-Invasive Evaluation of NAFLD Severity

🎙️ podcast version

Non-Invasive Evaluation of NAFLD Severity

Nonalcoholic fatty liver disease (NAFLD) and nonalcoholic steatohepatitis (NASH) are a leading cause of liver diseases worldwide, including hepatocellular carcinoma (HCC). In this review on non-invasive evaluation, Prof. Jérôme Boursier, France, presents a meta analysis focusing on the identification of patients with high risk profile and in need of specific management. Dr. Boursier reviews the two major families of non-invasive tests and discusses the sequential use of tests recommended in the EASL guidelines 2021.
Avatar photo

Prof. Jérôme Boursier

Prof. Jerome Boursier (MD, PhD) is an esteemed hepatologist and researcher from Angers University


Subscribe Our Newsletter To Get the Lastest Updates